Cargando…
High-level correction of the sickle mutation is amplified in vivo during erythroid differentiation
BACKGROUND: A point mutation in sickle cell disease (SCD) alters one amino acid in the β-globin subunit of hemoglobin, with resultant anemia and multiorgan damage that typically shortens lifespan by decades. Because SCD is caused by a single mutation, and hematopoietic stem cells (HSCs) can be harve...
Autores principales: | Magis, Wendy, DeWitt, Mark A., Wyman, Stacia K., Vu, Jonathan T., Heo, Seok-Jin, Shao, Shirley J., Hennig, Finn, Romero, Zulema G., Campo-Fernandez, Beatriz, Said, Suzanne, McNeill, Matthew S., Rettig, Garrett R., Sun, Yongming, Wang, Yu, Behlke, Mark A., Kohn, Donald B., Boffelli, Dario, Walters, Mark C., Corn, Jacob E., Martin, David I.K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9130532/ https://www.ncbi.nlm.nih.gov/pubmed/35633935 http://dx.doi.org/10.1016/j.isci.2022.104374 |
Ejemplares similares
-
CRISPR-Cas9 interrogation of a putative fetal globin repressor in human erythroid cells
por: Chung, Jennifer E., et al.
Publicado: (2019) -
Genome editing to model and reverse a prevalent mutation associated with myeloproliferative neoplasms
por: Baik, Ron, et al.
Publicado: (2021) -
Progress Toward In Vivo Use of siRNAs-II
por: Rettig, Garrett R, et al.
Publicado: (2012) -
Controlled Cycling and Quiescence Enables Efficient HDR in Engraftment-Enriched Adult Hematopoietic Stem and Progenitor Cells
por: Shin, Jiyung J., et al.
Publicado: (2020) -
Pure Erythroid Leukemia in a Sickle Cell Patient Treated with Hydroxyurea
por: Yadav, Dhiraj Kumar, et al.
Publicado: (2020)